CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −3,100 | $5.75 | $18K | 93,538 |
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −2,813 | $5.76 | $16K | 90,725 |
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −700 | $5.77 | $4K | 90,025 |
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −600 | $5.80 | $3K | 89,425 |
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −1,000 | $5.81 | $6K | 88,425 |
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −4,700 | $5.82 | $27K | 83,725 |
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −500 | $5.83 | $3K | 83,225 |
| 2010-12-22 | CALHOUN CHRISTOPHER J Chief Executive Officer | Sale | −100 | $5.86 | $586 | 83,125 |
| 2010-11-01 | Dean Lloyd H Director | Grant or award | +21,000 | $4.70 | $99K | 21,000 |
| 2010-11-01 | Dean Lloyd H Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2010-06-04 | SHIRAHAMA NORIO SEIJIRO President - Asia Pacific | Purchase | +1,500 | $4.57 | $7K | 10,200 |
| 2010-05-24 | HAWRAN PAUL W Director | Purchase | +5,000 | $4.65 | $23K | 60,610 |
| 2010-05-21 | Saad Mark E Chief Financial Officer | Purchase | +900 | $4.28 | $4K | 77,400 |
| 2010-05-21 | Saad Mark E Chief Financial Officer | Purchase | +4,100 | $4.29 | $18K | 81,500 |
| 2010-05-21 | Saad Mark E Chief Financial Officer | Purchase | +1,000 | $4.30 | $4K | 82,500 |
| 2010-05-19 | HAWRAN PAUL W Director | Purchase | +5,000 | $4.83 | $24K | 55,610 |
| 2010-02-09 | Hawkins Richard J Director | Grant or award | +943 | 4,085 | ||
| 2010-02-09 | Hawkins Richard J Director | Grant or award · Non-Qualifed Stock Option (Right to Buy) | +20,000 | 90,000 | ||
| 2010-02-09 | HENRIKSEN RONALD D Director | Grant or award | +1,568 | 52,092 | ||
| 2010-02-09 | HENRIKSEN RONALD D Director | Grant or award · Employee Stock Option | +25,000 | 300,000 |
Page 32 of 53 · 1,058 trades